Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Phase II single-arm study of palbociclib and cetuximab rechallenge in KRAS/NRAS/BRAF wild-type (KRAS WT) metastatic colorectal cancer (mCRC) patients (pts).
Authors
Jonathan D Sorah
UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC
Jonathan D Sorah , Dominic T. Moore , Matthew Reilley , Mohamed E. Salem , Hanna Kelly Sanoff , Tammy Triglianos , Autumn Jackson McRee , Michael Sangmin Lee
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Therapeutics
Clinical Trial Registration Number
NCT03446157
DOI
10.1200/JCO.2022.40.4_suppl.088
Abstract #
88
Poster Bd #
E1
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
An international, multicenter, randomized, double-blind, placebo-controlled, parallel-group phase 2 study of palbociclib (an oral CDK4/6 inhibitor) plus cetuximab in patients with recurrent/metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN).
First Author: Bhumsuk Keam
Poster
2015 ASCO Annual Meeting
A phase 3 open-label, randomized, multicenter study of imprime PGG in combination with cetuximab in patients with KRAS wild type metastatic colorectal cancer.
First Author: Richard Dale Huhn
Poster
2015 Gastrointestinal Cancers Symposium
Prevalence and outcomes of patients (pts) with EGFR S492R ectodomain mutations in ASPECCT: Panitumumab (pmab) vs. cetuximab (cmab) in pts with chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer (mCRC).
First Author: Timothy Jay Price
Poster
2015 Gastrointestinal Cancers Symposium
A phase 3 open-label, randomized, multicenter study of Imprime PGG in combination with cetuximab in patients with KRAS wild type metastatic colorectal cancer.
First Author: Richard Dale Huhn